AI tool aims to predict where liver cancer spreads next

NCT ID NCT07444905

Ongoing Knowledge-focused Sponsor: Tongji Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a machine learning tool that predicts the risk of liver cancer spreading to the lungs or bones. Over 1,500 adults with liver cancer but no signs of spread are being followed to see if the tool helps doctors make better decisions about monitoring. The tool gives a risk score, but doctors still choose the actual care. The goal is to see if this approach leads to earlier detection of metastases and better survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a more personalized and efficient surveillance strategy for liver cancer patients, potentially catching metastases earlier.
What could go wrong: This is an observational study, not a treatment trial. The tool may not improve outcomes or may be difficult to implement in real-world clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EVALUATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EVALUATION HCC - HEPATOCELLULAR CARCINOMA MACHINE LEARNING

Contacts and locations

Locations

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.